Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Feb 2009 12:39 PM
RNS
Result of EGM
09 Feb 2009 07:00 AM
PRN
Acquisition
26 Jan 2009 07:00 AM
PRN
Result of AGM
15 Jan 2009 09:24 AM
PRN
Acquisition of Theragenetics Limited
09 Jan 2009 07:00 AM
PRN
Acquisition(s)
08 Jan 2009 02:29 PM
RNS
Director/PDMR Shareholding
07 Jan 2009 07:00 AM
RNS
Issue of Equity
12 Dec 2008 12:06 PM
RNS
Final Results
20 Nov 2008 04:14 PM
RNS
Director/PDMR Shareholding
05 Nov 2008 12:42 PM
RNS
Issue of Equity
04 Nov 2008 07:00 AM
PRN
Final Results
13 Oct 2008 07:00 AM
PRN
Change of Adviser
11 Sep 2008 07:00 AM
PRN
Product Launch
21 Aug 2008 07:00 AM
PRN
Trading Statement
14 Aug 2008 11:03 AM
PRN
Product Development Partnership
28 Jul 2008 07:00 AM
PRN
Product Launch
23 Jul 2008 02:54 PM
PRN
Director/PDMR Shareholding
22 Jul 2008 04:24 PM
PRN
Director/PDMR Shareholding
11 Jul 2008 07:00 AM
PRN
Customer Agreement
14 Apr 2008 07:00 AM
PRN
Half-yearly Report
04 Apr 2008 05:20 PM
RNS
Director/PDMR Shareholding
31 Mar 2008 07:00 AM
RNS
Total Voting Rights
10 Mar 2008 03:12 PM
RNS
Issue of Equity
31 Jan 2008 11:36 AM
RNS
Total Voting Rights
07 Jan 2008 10:50 AM
PRN
Re Agreement
02 Jan 2008 05:14 PM
PRN
Issue of Equity
31 Dec 2007 07:00 AM
PRN
Total Voting Rights
14 Dec 2007 03:30 PM
PRN
Acquisition(s)
14 Dec 2007 03:05 PM
PRN
AGM Statement
21 Nov 2007 07:01 AM
RNS
Notice of AGM
14 Nov 2007 09:08 AM
PRN
Acquisition
09 Nov 2007 04:59 PM
PRN
Directorate Appointment
25 Sep 2007 07:00 AM
PRN
Final Results
03 Sep 2007 07:00 AM
PRN
Re Agreement
14 Aug 2007 03:59 PM
RNS
AIM Rule 26 Information
13 Aug 2007 07:00 AM
PRN
Re Agreement
31 Jul 2007 03:37 PM
RNS
Total Voting Rights
26 Jul 2007 09:53 AM
PRN
Issue of Equity
05 Jul 2007 07:00 AM
PRN
Re Agreement
25 Apr 2007 04:29 PM
PRN
Holding(s) in Company
10 Apr 2007 11:59 AM
PRN
Director Shareholding
05 Apr 2007 12:13 PM
PRN
Total Voting Rights
04 Apr 2007 07:00 AM
PRN
Placing and Appointment of joint broker
04 Apr 2007 07:00 AM
PRN
Product Launch
30 Jan 2007 01:51 PM
PRN
Interim Results
21 Dec 2006 08:44 AM
PRN
Total Voting Rights
29 Nov 2006 07:00 AM
PRN
Re Agreement
20 Oct 2006 03:40 PM
RNS
Change of accounting ref date
11 Oct 2006 11:12 AM
RNS
Annual Report and Accounts
19 Sep 2006 07:00 AM
PRN
Re Agreement

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100